Form 4 for PTGX Protagonist Therapeutics, Inc
Accepted 2024-03-11 00:00:00 ET · period of report 2024-03-07 · accession 0001104659-24-033132 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-11 | 2024-03-07 | PTGX | SELICK HAROLD E | Dir | M - OptEx | $1.89 | +6,490 | 28.0K | +30% | +$12.3K |
| D | 2024-03-11 | 2024-03-07 | PTGX | SELICK HAROLD E | Dir | M - OptEx | $0.00 | -6,490 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-07 | M | A | 6,490 | $1.89 | 27,996 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2024-03-07 | M | D | 6,490 | $0.00 | 0 | D | $1.89 · — to 2024-10-22 | 6,490 Common Stock | (F1) The stock option is fully vested. |